Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-10-04 00:00:00 ET · period of report 2022-09-30 · accession 0001562180-22-007011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Katkin Keith | Dir | S - Sale+OE | $25.06 | -4,101 | 32.0K | -11% | -$102.8K |
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Katkin Keith | Dir | M - OptEx | $8.11 | +4,101 | 32.6K | +14% | +$33.2K |
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Katkin Keith | Dir | M - OptEx | $0.00 | -4,101 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-04 | S | D | 223 | $25.00 | 32,000 | D | — | — | (F3) The sale price was $25.00. |
| 2 | Common | Common Stock | 2022-10-03 | S | D | 13 | $25.00 | 32,000 | D | — | — | (F3) The sale price was $25.00. |
| 3 | Common | Common Stock | 2022-10-04 | M | A | 223 | $8.93 | 32,223 | D | — | — | |
| 4 | Common | Common Stock | 2022-10-04 | S | D | 137 | $25.00 | 32,000 | D | — | — | (F3) The sale price was $25.00. |
| 5 | Common | Common Stock | 2022-10-04 | M | A | 137 | $7.88 | 32,137 | D | — | — | |
| 6 | Common | Common Stock | 2022-09-30 | M | A | 2,914 | $7.88 | 34,914 | D | — | — | |
| 7 | Common | Common Stock | 2022-10-03 | M | A | 13 | $8.93 | 32,013 | D | — | — | |
| 8 | Common | Common Stock | 2022-10-03 | S | D | 167 | $25.00 | 32,000 | D | — | — | (F3) The sale price was $25.00. |
| 9 | Common | Common Stock | 2022-10-03 | M | A | 167 | $7.88 | 32,167 | D | — | — | |
| 10 | Common | Common Stock | 2022-09-30 | S | D | 647 | $25.07 | 32,000 | D | — | — | (F2) The sale prices ranged from $25.00 to $25.215. |
| 11 | Common | Common Stock | 2022-09-30 | M | A | 647 | $8.93 | 32,647 | D | — | — | |
| 12 | Common | Common Stock | 2022-09-30 | S | D | 2,914 | $25.07 | 32,000 | D | — | — | (F2) The sale prices ranged from $25.00 to $25.215. |
| 13 | Derivative | Stock Options (Right to buy) | 2022-10-04 | M | D | 137 | $0.00 | 0 | D | $7.88 · — to 2029-06-10 | 137 Common Stock | (F4) This option is fully vested. |
| 14 | Derivative | Stock Options (Right to buy) | 2022-10-03 | M | D | 13 | $0.00 | 0 | D | $8.93 · — to 2028-05-23 | 13 Common Stock | (F4) This option is fully vested. |
| 15 | Derivative | Stock Options (Right to buy) | 2022-10-04 | M | D | 223 | $0.00 | 0 | D | $8.93 · — to 2028-05-23 | 223 Common Stock | (F4) This option is fully vested. |
| 16 | Derivative | Stock Options (Right to buy) | 2022-10-03 | M | D | 167 | $0.00 | 0 | D | $7.88 · — to 2029-06-10 | 167 Common Stock | (F4) This option is fully vested. |
| 17 | Derivative | Stock Options (Right to buy) | 2022-09-30 | M | D | 2,914 | $0.00 | 0 | D | $7.88 · — to 2029-06-10 | 2,914 Common Stock | (F4) This option is fully vested. |
| 18 | Derivative | Stock Options (Right to buy) | 2022-09-30 | M | D | 647 | $0.00 | 0 | D | $8.93 · — to 2028-05-23 | 647 Common Stock | (F4) This option is fully vested. |